Third Stock Analysis


USD 17.00  1.97  10.38%   

The latest bullish price patterns experienced by current Third Harmonic shareholders created some momentum for shareholders as it was traded today as low as 16.64 and as high as 17.44 per share. The company directors and management have been very successful in rebalancing the company assets at opportune times to take advantage of market volatility in September. The stock standard deviation of daily returns for 90 days investing horizon is currently 7.07. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Third Harmonic Bio partners.
Additionally, take a look at World Market Map.
The Third Harmonic stock analysis report makes it easy to digest most publicly released information about Third Harmonic and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Third Stock analysis module also helps to analyze the Third Harmonic price relationship with some important fundamental indicators such as market cap and management efficiency.

Third Stock Analysis Notes

About 43.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.28. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Third Harmonic Bio last dividend was issued on the August 6, 2014. The entity had 105:100 split on the February 11, 2011. Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts. Third Harmonic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people. To find out more about Third Harmonic Bio contact the company at 617-915-6680 or learn more at

Third Harmonic Bio Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Third Harmonic's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Third Harmonic Bio or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Third Harmonic Bio has very high historical volatility over the last 90 days
The company reported the previous year's revenue of 30.03 M. Net Loss for the year was (38.62 M) with profit before overhead, payroll, taxes, and interest of 30.63 M.
Third Harmonic Bio currently holds about 112.73 M in cash with (23.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 25.53, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 43.0% of the company outstanding shares are owned by corporate insiders
Latest headline from Ryder System, Harrow Health And Other Big Gainers From Tuesday By Benzinga - UK

Third Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 127.18 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Third Harmonic's market, we take the total number of its shares issued and multiply it by Third Harmonic's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of 0.71 % which means that it generated profit of $0.71 on every $100 spent on asset. This is way below average. Third Harmonic management efficiency ratios could be used to measure how well third harmonic bio manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 4th of October, Third Harmonic has the Risk Adjusted Performance of 0.0473, coefficient of variation of 3048.21, and Semi Deviation of 5.8. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Third Harmonic Bio, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Third Harmonic Bio, which can be compared to its competition. Please validate Third Harmonic Bio jensen alpha, as well as the relationship between the potential upside and skewness to decide if Third Harmonic is priced more or less accurately, providing market reflects its prevalent price of 17.0 per share. Given that Third Harmonic Bio has jensen alpha of 0.1556, we advise you to double-check Third Harmonic Bio's current market performance to make sure the company can sustain itself at a future point.

Third Harmonic Bio Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Kaufman Adaptive Moving Average allows the user to define Third Harmonic Bio range across which they want the smoothing.

Third Harmonic Bio Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Third Harmonic insiders, such as employees or executives, is commonly permitted as long as it does not rely on Third Harmonic's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Third Harmonic insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Third Harmonic Predictive Daily Indicators

Third Harmonic intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Third Harmonic stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Third Harmonic Forecast Models

Third Harmonic time-series forecasting models is one of many Third Harmonic's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Third Harmonic's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Third Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Third Harmonic prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Third shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Third Harmonic. By using and applying Third Stock analysis, traders can create a robust methodology for identifying Third entry and exit points for their positions.
Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts. Third Harmonic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Third Harmonic to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Alpha Finder Now


Alpha Finder

Use alpha and beta coefficients to find investment opportunities after accounting for the risk
All  Next Launch Module
Additionally, take a look at World Market Map. You can also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for analysis

When running Third Harmonic Bio price analysis, check to measure Third Harmonic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Third Harmonic is operating at the current time. Most of Third Harmonic's value examination focuses on studying past and present price action to predict the probability of Third Harmonic's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Third Harmonic's price. Additionally, you may evaluate how the addition of Third Harmonic to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Is Third Harmonic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Third Harmonic. If investors know Third will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Third Harmonic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Third Harmonic Bio is measured differently than its book value, which is the value of Third that is recorded on the company's balance sheet. Investors also form their own opinion of Third Harmonic's value that differs from its market value or its book value, called intrinsic value, which is Third Harmonic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Third Harmonic's market value can be influenced by many factors that don't directly affect Third Harmonic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Third Harmonic's value and its price as these two are different measures arrived at by different means. Investors typically determine Third Harmonic value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Third Harmonic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.